Literature DB >> 31062281

The Impact of Genetic Counseling Educational Tools on Patients' Knowledge of Molecular Testing Terminology.

Brianna A McDaniels1, Rachel S Hianik2, Cecelia Bellcross3, Walid L Shaib3,2, Jeffrey Switchenko4, Margie D Dixon3,2, Jane L Meisel3,2, Keerthi Gogineni3,2, Rebecca D Pentz3,2.   

Abstract

Molecular testing is increasingly being integrated into cancer management. Despite rapid advancements, little work has been done to explore strategies for communicating with patients undergoing molecular tumor testing. This study evaluated the impact of genetic counseling educational tools on improving patients' understanding of key terms related to molecular testing. A genetic counseling intern designed a picture book to explain six words found in prior research to be difficult to understand (mutation, germline mutation, somatic mutation, biomarker, molecular testing, and targeted therapy). Participants who had previously discussed molecular testing with their oncologist were asked to define the terms. The same participants then received an explanation of each term either from the intern using the picture book in person or from a video presentation of the picture book. They were then asked to redefine each term afterward. The difference between the number of terms defined correctly pre- and post-intervention was compared between presentations. Sixty-three patients with melanoma, colon, lung, or breast cancer were recruited. After both interventions, correct understanding rates improved for all six terms, with significant improvement for germline mutation (p < 0.001), somatic mutation (p < 0.001), biomarker (p < 0.001), and molecular testing (p < 0.001). Understanding of targeted therapy improved significantly (p = 0.011) for the video presentation only. Mean change in knowledge scores did not differ between the two interventions (intern presentation 3.2 vs. video 2.9, p = 0.428). Our data suggest that genetic counseling educational tools can increase patient understanding of terms used to describe molecular testing.

Entities:  

Keywords:  Genetic; Genetic counseling; Genetic testing; Molecular testing; Somatic; Tumor profiling; Tumor sequencing; Video

Year:  2020        PMID: 31062281      PMCID: PMC6834865          DOI: 10.1007/s13187-019-01535-0

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  24 in total

1.  Video-based educational tool improves patient comprehension of common prostate health terminology.

Authors:  Daniel S Wang; Ashesh B Jani; Musu Sesay; Caroline G Tai; Daniel K Lee; Katharina V Echt; Michael G Goodman; Kerry E Kilbridge; Viraj A Master
Journal:  Cancer       Date:  2014-11-12       Impact factor: 6.860

2.  Assessment of the use and feasibility of video to supplement the genetic counseling process: a cancer genetic counseling perspective.

Authors:  J E Axilbund; L A Hamby; D B Thompson; S J Olsen; C A Griffin
Journal:  J Genet Couns       Date:  2005-06       Impact factor: 2.537

Review 3.  Clinical implications of the cancer genome.

Authors:  Laura E Macconaill; Levi A Garraway
Journal:  J Clin Oncol       Date:  2010-10-25       Impact factor: 44.544

Review 4.  Low health literacy and health outcomes: an updated systematic review.

Authors:  Nancy D Berkman; Stacey L Sheridan; Katrina E Donahue; David J Halpern; Karen Crotty
Journal:  Ann Intern Med       Date:  2011-07-19       Impact factor: 25.391

5.  Developing and assessing the utility of a You-Tube based clinical genetics video channel for families affected by inherited tumours.

Authors:  G E Jones; J H Singletary; A Cashmore; V Jain; J Abhulimhen; J Chauhan; H V Musson; J G Barwell
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

6.  Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.

Authors:  Mark G Kris; Bruce E Johnson; Lynne D Berry; David J Kwiatkowski; A John Iafrate; Ignacio I Wistuba; Marileila Varella-Garcia; Wilbur A Franklin; Samuel L Aronson; Pei-Fang Su; Yu Shyr; D Ross Camidge; Lecia V Sequist; Bonnie S Glisson; Fadlo R Khuri; Edward B Garon; William Pao; Charles Rudin; Joan Schiller; Eric B Haura; Mark Socinski; Keisuke Shirai; Heidi Chen; Giuseppe Giaccone; Marc Ladanyi; Kelly Kugler; John D Minna; Paul A Bunn
Journal:  JAMA       Date:  2014-05-21       Impact factor: 56.272

7.  American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.

Authors:  Karen H Lu; Marie E Wood; Molly Daniels; Cathy Burke; James Ford; Noah D Kauff; Wendy Kohlmann; Noralane M Lindor; Therese M Mulvey; Linda Robinson; Wendy S Rubinstein; Elena M Stoffel; Carrie Snyder; Sapna Syngal; Janette K Merrill; Dana Swartzberg Wollins; Kevin S Hughes
Journal:  J Clin Oncol       Date:  2014-02-03       Impact factor: 44.544

8.  Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.

Authors:  Eric Van Cutsem; Claus-Henning Köhne; István Láng; Gunnar Folprecht; Marek P Nowacki; Stefano Cascinu; Igor Shchepotin; Joan Maurel; David Cunningham; Sabine Tejpar; Michael Schlichting; Angela Zubel; Ilhan Celik; Philippe Rougier; Fortunato Ciardiello
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

9.  Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.

Authors:  Fiona A Miller; Robin Z Hayeems; Jessica P Bytautas; Philippe L Bedard; Scott Ernst; Hal Hirte; Sebastien Hotte; Amit Oza; Albiruni Razak; Stephen Welch; Eric Winquist; Janet Dancey; Lillian L Siu
Journal:  Eur J Hum Genet       Date:  2013-07-17       Impact factor: 4.246

10.  Projecting the Supply and Demand for Certified Genetic Counselors: a Workforce Study.

Authors:  Jennifer M Hoskovec; R L Bennett; M E Carey; J E DaVanzo; M Dougherty; S E Hahn; B S LeRoy; S O'Neal; J G Richardson; C A Wicklund
Journal:  J Genet Couns       Date:  2017-10-20       Impact factor: 2.537

View more
  4 in total

Review 1.  Patient and public understanding of the concept of 'personalised medicine' in relation to cancer treatment: a systematic review.

Authors:  Jed Botham; Valerie Shilling; John Jones
Journal:  Future Healthc J       Date:  2021-11

2.  Stakeholders Perceptions of Barriers to Precision Medicine Adoption in the United States.

Authors:  Monica M Schroll; Arushi Agarwal; Olivia Foroughi; Emily Kong; Omar Perez; Daryl Pritchard; Tom Breur; Kristen Garner Amanti; Gary Gustavsen
Journal:  J Pers Med       Date:  2022-06-22

Review 3.  Genetic risk factors in melanoma etiopathogenesis and the role of genetic counseling: A concise review.

Authors:  Nikola Serman; Semir Vranic; Mislav Glibo; Ljiljana Serman; Zrinka Bukvic Mokos
Journal:  Bosn J Basic Med Sci       Date:  2022-09-16       Impact factor: 3.759

4.  Videos improve patient understanding of chemotherapy terminology in a rural setting.

Authors:  Hannah Claire Sibold; Mary Catherine Thomson; Rachel Hianik; Eli R Abernethy; Gavin P Campbell; Bradley Sumrall; Melissa Dillmon; Josh Simmons; Jeffrey M Switchenko; Margie D Dixon; Rebecca D Pentz
Journal:  Cancer       Date:  2021-07-21       Impact factor: 6.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.